BIOY vs. CHPY
BIOY (GraniteShares YieldBOOST Biotech ETF) and CHPY (YieldMax Semiconductor Portfolio Option Income ETF) are both Derivative Income funds. Both are actively managed. At a 0.16 correlation, their price movements are largely independent. BIOY charges 1.07%/yr vs 0.99%/yr for CHPY.
Performance
BIOY vs. CHPY - Performance Comparison
Loading charts...
Returns By Period
BIOY
- 1D
- -3.35%
- 1M
- -2.48%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
CHPY
- 1D
- 0.07%
- 1M
- -16.49%
- 6M
- 45.51%
- YTD
- 60.59%
- 1Y
- 94.78%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 104.00%
BIOY vs. CHPY - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
BIOY GraniteShares YieldBOOST Biotech ETF | -3.36% |
CHPY YieldMax Semiconductor Portfolio Option Income ETF | 11.97% |
Correlation
The correlation between BIOY and CHPY is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since May 5, 2026 | 0.16 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIOY vs. CHPY — Risk / Return Rank
BIOY
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
CHPY
BIOY vs. CHPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GraniteShares YieldBOOST Biotech ETF (BIOY) and YieldMax Semiconductor Portfolio Option Income ETF (CHPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIOY | CHPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.42 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 5.22 | — |
| Martin ratioReturn relative to average drawdown | — | 20.81 | — |
Loading charts...
Drawdowns
BIOY vs. CHPY - Drawdown Comparison
The maximum BIOY drawdown since its inception was -6.64%, smaller than the maximum CHPY drawdown of -18.27%. Use the drawdown chart below to compare losses from any high point for BIOY and CHPY.
Loading charts...
Drawdown Indicators
| BIOY | CHPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -6.64% | -18.27% | +11.63% |
Max Drawdown (1Y)Largest decline over 1 year | — | -18.27% | — |
Current DrawdownCurrent decline from peak | -6.64% | -18.22% | +11.58% |
Average DrawdownAverage peak-to-trough decline | -2.16% | -2.58% | +0.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 4.57% | — |
Volatility
BIOY vs. CHPY - Volatility Comparison
Loading charts...
Volatility by Period
| BIOY | CHPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 17.75% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 31.44% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.55% | 35.88% | -17.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.55% | 37.81% | -19.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.55% | 37.81% | -19.26% |
BIOY vs. CHPY - Expense Ratio Comparison
BIOY has a 1.07% expense ratio, which is higher than CHPY's 0.99% expense ratio.
Dividends
BIOY vs. CHPY - Dividend Comparison
BIOY's dividend yield for the trailing twelve months is around 13.82%, less than CHPY's 36.46% yield.
| Position | TTM | 2025 |
|---|---|---|
BIOY GraniteShares YieldBOOST Biotech ETF | 13.82% | 0.00% |
CHPY YieldMax Semiconductor Portfolio Option Income ETF | 36.46% | 28.19% |
Frequently Asked Questions
BIOY and CHPY have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CHPY is cheaper at 0.99% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CHPY is cheaper with a 0.99% expense ratio, compared with 1.07% for BIOY.
CHPY has the higher dividend yield at 36.46%, compared with 13.82% for BIOY.
They also come from different issuers: GraniteShares and YieldMax. Their fees differ too: 1.07% for BIOY and 0.99% for CHPY.
Find the right allocation for BIOY and CHPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer